Return to homepagePandemic Pact

Assess population-wide immunity to SARS-CoV-2 using serological testing

  • Funded by Fondation pour la Recherche Médicale
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $243,756

  • Funder

    Fondation pour la Recherche Médicale

  • Principal Investigator

    Michael WHITE

  • Research Location

    France

  • Lead Research Institution

    Institut Pasteur

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The CorPopImm project contributes to the development of serological tests, tests that detect antibodies in the blood against Sars-CoV-2, a sign of immunity left by infection to Covid-19. These tests must be deployable on a large scale and effective in the long term. This will then enable the population's immunity to the virus to be assessed.